Microsatellite instability in Japanese female patients with triple-negative breast cancer

BACKGROUND: It is important to identify biomarkers for triple-negative breast cancers (TNBCs). Recently, pembrolizumab, an immune checkpoint inhibitor (ICI) for programmed cell death 1 (PD-1), was approved as a treatment strategy for unresectable or metastatic tumor with high-frequency microsatellit...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Breast Cancer
Auteurs principaux: Kurata, Kanako, Kubo, Makoto, Kai, Masaya, Mori, Hitomi, Kawaji, Hitomi, Kaneshiro, Kazuhisa, Yamada, Mai, Nishimura, Reiki, Osako, Tomofumi, Arima, Nobuyuki, Okido, Masayuki, Oda, Yoshinao, Nakamura, Masafumi
Format: Artigo
Langue:Inglês
Publié: Springer Japan 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7196096/
https://ncbi.nlm.nih.gov/pubmed/31907878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12282-019-01043-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires